FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W101379675> ?p ?o ?g. }

• W101379675 endingPage "49" @default.
• W101379675 startingPage "229" @default.
• W101379675 abstract "At the present time, corticosteroids are still the most effective class of drugs for the treatment of ocular inflammation. However, since their prolonged use may result in severe ocular side effects, it would be therapeutically beneficial to develop nonsteroidal anti-inflammatory drugs that have similar or greater efficacy than steroids, but do not share their ocular side effects. Several currently available non-steroidal drugs have been used clinically as prophylactic or therapeutic agents for the following: 1. Prevention of pupillary constriction during intraocular surgery (cataract extraction). 2. Prevention of postoperative inflammation, i.e., incidence of anterior chamber cellular reaction and aqueous flare (breakdown of blood-aqueous barrier) and IOP rise following cataract surgery, intraocular lens implantation, and argon laser trabeculoplasty. 3. Prevention of contact lens induced corneal neovascularization. 4. Improvement of lens opacity (bendazac). 5. Prevention of cystoid macular edema following intraocular surgery. Treatment over long-term period may be effective; postoperative treatment is ineffective. 6. Prevention of conjunctival hyperemia. Some prophylactic ocular uses such as prevention of surgical miosis or postoperative fluorescein leakage have been reported to be successful. However, it is unclear whether the reported success reflected the pharmacological effects due to inhibition of the AA cascade - and hence, reflects the role of some eicosanoids in surgical miosis or postoperative fluorescein leakage - or reflect the effects of these drugs on unexplored physiological or pharmacological mechanisms. For example, pretreatment with flurbiprofen to prevent surgical miosis was based on the assumption that PGs are potent miotic agents in all mammals, including humans. It remains to be established however, whether the small reduction in the extent of pupillary miosis is due to prevention of PG synthesis by this drug or to the prevention of the synthesis of other AA products, such as prostacyclin and thromboxane or possibly to some entirely different mechanism. Prevention of post-surgical fluorescein leakage by prophylactic pre and/or post surgical treatment with a variety of nonsteroidal anti-inflammatory agents is also assumed to be due to inhibition of intraocular PG synthesis, although the possibility that it is due to prevention of the synthesis of prostacyclin or TxA2 has not been ruled out. Even more important, it has not been demonstrated that prevention of this post operative fluorescein leakage reflects the prevention or inhibition of true CME and associated loss of visual acuity.(ABSTRACT TRUNCATED AT 400 WORDS)" @default.
• W101379675 created "2016-06-24" @default.
• W101379675 creator A5043685375 @default.
• W101379675 creator A5086764582 @default.
• W101379675 date "1989-01-01" @default.
• W101379675 modified "2023-09-23" @default.
• W101379675 title "Inhibitors of the arachidonic acid cascade in the management of ocular inflammation." @default.
• W101379675 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/2508126" @default.
• W101379675 hasPublicationYear "1989" @default.
• W101379675 type Work @default.
• W101379675 sameAs 101379675 @default.
• W101379675 citedByCount "10" @default.
• W101379675 countsByYear W1013796752015 @default.
• W101379675 crossrefType "journal-article" @default.
• W101379675 hasAuthorship W101379675A5043685375 @default.
• W101379675 hasAuthorship W101379675A5086764582 @default.
• W101379675 hasConcept C118487528 @default.
• W101379675 hasConcept C126322002 @default.
• W101379675 hasConcept C2775888743 @default.
• W101379675 hasConcept C2776740260 @default.
• W101379675 hasConcept C2776914184 @default.
• W101379675 hasConcept C2777625524 @default.
• W101379675 hasConcept C2777724181 @default.
• W101379675 hasConcept C2778257484 @default.
• W101379675 hasConcept C2779567214 @default.
• W101379675 hasConcept C2781000538 @default.
• W101379675 hasConcept C2781092963 @default.
• W101379675 hasConcept C2781104129 @default.
• W101379675 hasConcept C42219234 @default.
• W101379675 hasConcept C71924100 @default.
• W101379675 hasConcept C98274493 @default.
• W101379675 hasConceptScore W101379675C118487528 @default.
• W101379675 hasConceptScore W101379675C126322002 @default.
• W101379675 hasConceptScore W101379675C2775888743 @default.
• W101379675 hasConceptScore W101379675C2776740260 @default.
• W101379675 hasConceptScore W101379675C2776914184 @default.
• W101379675 hasConceptScore W101379675C2777625524 @default.
• W101379675 hasConceptScore W101379675C2777724181 @default.
• W101379675 hasConceptScore W101379675C2778257484 @default.
• W101379675 hasConceptScore W101379675C2779567214 @default.
• W101379675 hasConceptScore W101379675C2781000538 @default.
• W101379675 hasConceptScore W101379675C2781092963 @default.
• W101379675 hasConceptScore W101379675C2781104129 @default.
• W101379675 hasConceptScore W101379675C42219234 @default.
• W101379675 hasConceptScore W101379675C71924100 @default.
• W101379675 hasConceptScore W101379675C98274493 @default.
• W101379675 hasLocation W1013796751 @default.
• W101379675 hasOpenAccess W101379675 @default.
• W101379675 hasPrimaryLocation W1013796751 @default.
• W101379675 hasRelatedWork W101379675 @default.
• W101379675 hasRelatedWork W1164834395 @default.
• W101379675 hasRelatedWork W2038795379 @default.
• W101379675 hasRelatedWork W2056529954 @default.
• W101379675 hasRelatedWork W2082906689 @default.
• W101379675 hasRelatedWork W2090981337 @default.
• W101379675 hasRelatedWork W2138524354 @default.
• W101379675 hasRelatedWork W2364599975 @default.
• W101379675 hasRelatedWork W2486422016 @default.
• W101379675 hasRelatedWork W2616477326 @default.
• W101379675 hasVolume "312" @default.
• W101379675 isParatext "false" @default.
• W101379675 isRetracted "false" @default.
• W101379675 magId "101379675" @default.
• W101379675 workType "article" @default.